DFFN - Spark Newswire

1 minute read

News

Diffusion Pharmaceuticals Sends Letter To Stockholders Highlighting Strength Of Board Leadership And Positive Progress In Strategic Review, Cautioning Stockholders Regarding LifeSci’s History Of Stockholder Value Destruction And Self-Dealing

Today, 4:26 PM

Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process Diffusion received bids from more than 15 companies participating in

DFFN

2 minute read

LifeSci Special Opportunities Responded to Recent Press Release Issued by Diffusion Pharmaceuticals

By Charles Gross

Today, 4:26 PM

LifeSci Special Opportunities Master Fund Ltd. ("LifeSci Special Opportunities" or "we"), the holder of 96,976 shares of common stock of Diffusion Pharmaceuticals Inc.

DFFN

2 minute read

News

Diffusion Pharmaceuticals Announces Strategic Review Process To Evaluate Value-Enhancing Alternatives Including Opportunities To Better Leverage TSC

By Benzinga Newsdesk

Today, 4:26 PM

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), a biopharmaceutical company developing novel therapies that may enhance the body's ability to deliver oxygen to areas

DFFN

1 minute read

HC Wainwright & Co. Upgrades Diffusion Pharmaceuticals to Buy, Announces $9.5 Price Target

By Benzinga Newsdesk

Today, 4:26 PM

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Diffusion Pharmaceuticals (NASDAQ:DFFN) from Neutral to Buy and announces $9.5 price target.

DFFN

1 minute read

Diffusion Pharmaceuticals To Initiate Phase 2 Trial In Patients With Glioblastoma Multiforme Incorporating Innovative Imaging Methodology To Evaluate Tumor Oxygenation

By Benzinga Newsdesk

Today, 4:26 PM

Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium crocetinate (“TSC”) in newly diagnosed glioblastoma multiforme (“GBM”)

DFFN

1 minute read

News

Diffusion Pharmaceuticals Announces Effects In Altitude Trial

By Benzinga Newsdesk

Today, 4:26 PM

Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the exercise interval Positive effects on post-exercise recovery based when comparing measurements 10 min post-exercise to

DFFN

4 minute read

62 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:26 PM

Gainers Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5.00 per share.

AFIB

1 minute read

5 Stocks Halted In Tuesday’s Session

By AJ Fabino

Today, 4:26 PM

A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to the markets. Here are all the stocks halted on a circuit breaker today, according to Benzinga Pro.

DFFN